Eli Lilly and Company (NYSE: LLY) has announced its plan to issue €600 million in aggregate principal in the amount of 0.50% notes with 12-year maturity as part of its Environmental, Social and Governance (ESG) strategy. In May, the company announced that it had updated its Environmental, Social and Governance (ESG) strategy, bolstering its investment…
U.S. government halts use of Lilly’s bamlanivimab monotherapy
The spread of SARS-CoV-2 variants has convinced the U.S. government to stop using Lilly’s COVID-19 monoclonal antibody therapy bamlanivimab when used alone. The U.S. government will continue using bamlanivimab when paired with etesevimab, another monoclonal antibody. The government pointed to the rising number of SARS-CoV-2 variants across the country as the reasoning behind the decision.…
Eli Lilly CFO departs amid accusations of ‘inappropriate’ communications with staff
Eli Lilly (NYSE:LLY) has announced that its chief financial officer Joshua Smiley has resigned. An independent investigation with external counsel discovered “consensual though inappropriate” communications between Smiley and a number of employees, according to a Lilly statement. Lilly has installed a replacement, Anat Ashkenazi, who has worked at the company for almost 20 years. “We are…